A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma.
Alsuwaidan A, Koduru P, Fuda F, Manuel Jaso J, Chen M, Rosado F, Luu HS, Sweed N, Garcia R, Doucet M, Desai NB, Kumar KA, Awan FT, Ramakrishnan Geethakumari P, Chen W.
Alsuwaidan A, et al. Among authors: koduru p.
Am J Clin Pathol. 2022 Sep 2;158(3):338-344. doi: 10.1093/ajcp/aqac047.
Am J Clin Pathol. 2022.
PMID: 35511691